The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.

Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.

Columnist Candace Semien considers the rules, both written and unspoken, about how to maintain a healthy patient-doctor relationship.

The U.S. Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to Fate's FT819 for lupus.

Columnist Candace Semien is putting her body on a performance improvement plan so that she handles the Job of Life as best she can.

As we flip the page to a new year, the pull of hustle culture on social media hasn’t seemed to change. Messages urge us to do more, achieve more, and push harder. But for those of us living with lupus ...

The FDA granted fast track designation to SC291 as a potential treatment for hard-to-manage systemic lupus erythematosus (SLE).

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

Scientists tracking the genetic cause of lupus, focusing on mutations increasing TLR7 activity, aim to personalize treatment for patients.

Among 40 people with lupus surveryed in Pakistan, all but two showed symptoms of depression, which correlated with disease severity.

Ah, the changing seasons. Spring is finally here, and for many people, it’s an exciting time of rejuvenation, of shedding winter coats and embracing the sun’s warmth. But for those of us with chronic ...